Literature DB >> 27165205

Trends in Incidence of Common Cancers in Iran.

Mostafa Enayatrad1, Maryam Mirzaei, Hamid Salehiniya, Mohammad Reza Karimirad, Siavash Vaziri, Fiezollah Mansouri, Asieh Moudi.   

Abstract

Cancer is a major public health problem in Iran. The aim of this study was to evaluate trends in incidence of ten common cancers in Iran, based on the national cancer registry reports from 2004 to 2009. This epidemiological study was carried out based on existing age-standardized estimate cancer data from the national report on cancer registry/Ministry of Health in Iran. The obtained data were analyzed by test for linear trend and P ≥ 0.05 was taken as the significant level. Totals of 41,169 and 32,898 cases of cancer were registered in men and females, respectively, during these years. Overall age-standard incidence rates (ASRs) per 100,000 population according to primary site weres 125.6 and 113.4 in males and females, respectively. Between 2004 and 2009, the ten most common cancers (excluding skin cancer) were stomach (16.2), bladder (12.6), prostate (11), colon-rectum (10.14), hematopoeitic system (7.1), lung (6.1), esophagus (6.4), brain (3.2), lymph node (3.8) and larynx (3.4) in males; and in females were breast (27.4), colon-rectum (9.3), stomach (7.6), esophagus (6.4), hematopoeitic system (4.9), thyroid (3.9), ovary (3.6), corpus uteri (2.9), bladder (3.2) and lung (2.6). Moreover, results showed that skin cancer was estimated as the most common cancer in both sexes. The lowest and the highest incidence in females and males were reported respectively in 2004 and 2009. Over this period, the incidence of cancer in both sexes has been significantly increasing (p<0.01). Like other less developed and epidemiologically transitioning countries, the trend of age-standardized incidence rate of cancer in Iran is rising. Due to the increasing trends, the future burden of cancer in the Iran is going to be acute with the expected increases in aging populations. Determining and controlling potential risk factors of cancer should hopefully lead to decrease in its burden.

Entities:  

Mesh:

Year:  2016        PMID: 27165205     DOI: 10.7314/apjcp.2016.17.s3.39

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Predicting Effects of Clinicopathological Variables on Her2 Gene Amplification by Chromogenic in situ Hybridization (CISH) in IHC Her2 (2+) Breast Cancer Patients; A Study from Iran.

Authors:  Mohammad Hashemi Bahremani; Abdolali Ebrahimi; Mohaddese Fallahi
Journal:  Iran J Pathol       Date:  2020-04-21

2.  Middle-aged Health Checks Program Outputs in Non-communicable Diseases Screening in Iran.

Authors:  Marjan Movahedi; Ziba Farajzadegan; Reza Khadivi
Journal:  Int J Prev Med       Date:  2019-08-01

3.  The role of immunohistochemistry expression of COX-2 in differentiating pigmented benign and malignant skin neoplasms.

Authors:  Maryam Ghasemi; Parvaneh Afshar; Somayeh Sheidaei; Yosef Moeini; Lale Vahedi Larijani
Journal:  Med J Islam Repub Iran       Date:  2019-07-25

4.  National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990.

Authors:  Bahar Ataeinia; Sahar Saeedi Moghaddam; Mahsima Shabani; Kimiya Gohari; Ali Sheidaei; Nazila Rezaei; Shohreh Naderimagham; Erfan Ghasemi; Mahtab Rouhifard Khalilabad; Shahin Roshani; Yosef Farzi; Farshad Farzadfar
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

Review 5.  Epidemiological Study of Lung Cancer in Iran: A Systematic Review.

Authors:  Hamid Salehiniya; Mohammadkarim Bahadori; Ghader Ghanizadeh; Mehdi Raei
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

6.  Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran.

Authors:  Hamid Mazdak; Zahra Tolou-Ghamari
Journal:  Arab J Urol       Date:  2018-01-17

Review 7.  Bladder Cancer in Iran: An Epidemiological Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Hamid Salehiniya
Journal:  Res Rep Urol       Date:  2020-03-05

8.  System Delay in Breast Cancer Diagnosis in Gaza Strip, Palestine.

Authors:  Samira S Abo Al-Shiekh; Yasser S Alajerami; Bothyna B Etewa; Aymen M Elsous
Journal:  J Oncol       Date:  2019-12-11       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.